Table 2 Participant and neonatal health outcomes with fisher’s exact test results for association
% (N) DENV and/or ZIKV IgM+ (N = 48) | % (N) DENV and ZIKV IgM- (N = 150) | % (N) study population (N = 198) | *P-value Fisher’s | |
|---|---|---|---|---|
Pregnancy Outcomes | ||||
Any complications | 16.7% (8) | 24.0% (36) | 22.2% (44) | 0.325 |
Gestational Diabetes | 0% (0) | 2.7% (4) | 2.0% (4) | 0.574 |
Threat of miscarriage | 12.5% (6) | 8.7% (13) | 9.6% (19) | 0.411 |
Placenta previa or acreta | 0% (0) | 2.7% (4) | 2.0% (4) | 0.574 |
Breech birth | 4.2% (2) | 4.0% (6) | 4.0% (8) | 1.0 |
Urinary tract infection (UTI) during pregnancy | 2.1% (1) | 2.7% (4) | 2.5% (5) | 1.0 |
Labor and Delivery Outcomes | ||||
Cesarean section (c-section) | 43.8% (21) | 58.7% (88) | 55.1% (109) | 0.125 |
Any Complication | 6.3% (3) | 13.3% (20) | 11.6% (23) | 0.296 |
Premature rupture of membranes (PROM) | 4.2% (2) | 6.0% (9) | 5.6% (11) | 1.0 |
Neonatal Birth Outcomes | ||||
Any symptom | 6.25% (3) | 11.3% (17) | 10.1% (20) | 0.416 |
Low birthweight | 8.3% (4) | 7.3% (11) | 7.6% (15) | 0.757 |
Apgar 1 min < 9 | 8.3% (4) | 6.7% (10) | 7.1% (14) | 0.746 |
Apgar 5 min < 9 | 0% (0) | 2.0% (3) | 1.5% (3) | 1.0 |
Admitted to neonatal intensive care (NICU) | 12.5% (6) | 22.7% (34) | 20.2% (40) | 0.151 |
Premature birth | 10.4% (5) | 4.0% (6) | 5.6% (11) | 0.135 |
Meconium aspiration syndrome (MAS) | 0% (0) | 3.3% (5) | 2.5% (5) | 0.593 |
Acute respiratory distress syndrome (ARDS) | 4.2% (2) | 6.0% (9) | 5.6% (11) | 1.0 |
Respiratory assistance (hood) | 4.2% (2) | 6.0% (9) | 5.6% (11) | 1.0 |